Pluribus Labs’s L3Harris LHX Stock Holding History

Pluribus Labs’s Portfolio LHX Stock Details LHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,760	Closed	-$589K	–	156
2021 Q4	$589K	Buy	+2,760	New	+$612K	0.62%	34

Other funds holding LHX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Pluribus Labs's LHX Position: Q1 2022 in Review

Pluribus Labs sold out of L3Harris (LHX) in Q1 2022, closing a stake of 2,760 shares — an estimated $589K sold.

Pluribus Labs first reported a position in LHX in Q4 2021 and held it in 1 quarter. The position peaked at $589K in Q4 2021. 1,236 funds tracked by Wall St. Rank hold LHX as of Q1 2022.

Pluribus Labs reported no remaining L3Harris position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 2,760 L3Harris shares in Q1 2022, an estimated $589K.
Pluribus Labs first reported a position in L3Harris in Q4 2021 and held it in 1 quarter.
Pluribus Labs's L3Harris position peaked at $589K in Q4 2021.
1,236 funds tracked by Wall St. Rank held L3Harris as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.